Manulife (Manufacturers Life Insurance)
CSTE icon

Manulife (Manufacturers Life Insurance)’s Caesarstone CSTE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CSTE Stock Details CSTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,330
Closed -$96.2K – 2967
2022
Q3 		$96.2K Sell
10,330
-409
-4% -$3.94K ﹤0.01% 2819
2022
Q2 		$98K Sell
10,739
-321
-3% -$3.07K ﹤0.01% 2913
2022
Q1 		$116K Sell
11,060
-2,897
-21% -$34.3K ﹤0.01% 2936
2021
Q4 		$158 Sell
13,957
-276
-2% -$3.31K ﹤0.01% 2971
2021
Q3 		$177K Sell
14,233
-763
-5% -$10.2K ﹤0.01% 3024
2021
Q2 		$221K Buy
14,996
+1,339
+10% +$20.2K ﹤0.01% 3033
2021
Q1 		$188K Sell
13,657
-1,166
-8% -$15.4K ﹤0.01% 2916
2020
Q4 		$191K Buy
14,823
+900
+6% +$10.3K ﹤0.01% 2797
2020
Q3 		$136K Hold
13,923
– – ﹤0.01% 2714
2020
Q2 		$155K Sell
13,923
-834
-6% -$8.78K ﹤0.01% 2607
2020
Q1 		$156K Buy
14,757
+1,120
+8% +$13.7K ﹤0.01% 2432
2019
Q4 		$188K Sell
13,637
-543
-4% -$8.71K ﹤0.01% 2618
2019
Q3 		$236K Sell
14,180
-12
-0.1% -$183 ﹤0.01% 2467
2019
Q2 		$213K Buy
+14,192
New +$212K ﹤0.01% 2600
2018
Q3 		– Sell
-17,960
Closed -$271K – 3103
2018
Q2 		$271K Buy
17,960
+1,001
+6% +$17.2K ﹤0.01% 2868
2018
Q1 		$333K Buy
16,959
+273
+2% +$5.89K ﹤0.01% 2634
2017
Q4 		$366K Sell
16,686
-194
-1% -$4.98K ﹤0.01% 2540
2017
Q3 		$503K Sell
16,880
-226
-1% -$7.07K ﹤0.01% 2267
2017
Q2 		$600K Sell
17,106
-29,833
-64% -$1.12M ﹤0.01% 2150
2017
Q1 		$1.7M Buy
46,939
+18,689
+66% +$602K ﹤0.01% 1481
2016
Q4 		$809K Sell
28,250
-242,525
-90% -$7.7M ﹤0.01% 1780
2016
Q3 		$10.2M Sell
270,775
-14,867
-5% -$563K 0.02% 702
2016
Q2 		$9.93M Sell
285,642
-36,981
-11% -$1.37M 0.02% 694
2016
Q1 		$11.2M Buy
322,623
+9,697
+3% +$346K 0.01% 626
2015
Q4 		$13.6K Sell
312,926
-400,722
-56% -$15.3M 0.01% 556
2015
Q3 		$21.7K Buy
713,648
+493,789
+225% +$25.8M 0.02% 436
2015
Q2 		$15.1K Sell
219,859
-128,320
-37% -$7.93M 0.02% 515
2015
Q1 		$21.1K Sell
348,179
-363,511
-51% -$22.4M 0.03% 434
2014
Q4 		$42.6K Buy
711,690
+668,381
+1,543% +$38M 0.06% 238
2014
Q3 		$2.24K Buy
+43,309
New +$2.16M ﹤0.01% 1295

Other funds holding CSTE

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CSTE Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Caesarstone (CSTE) in Q4 2022, closing a stake of 10,330 shares — an estimated $96.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CSTE in Q3 2014 and held it in 30 quarters. The position peaked at $11.2M in Q1 2016. 89 funds tracked by Wall St. Rank hold CSTE as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Caesarstone position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,330 Caesarstone shares in Q4 2022, an estimated $96.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Caesarstone in Q3 2014 and held it in 30 quarters.
  • Manulife (Manufacturers Life Insurance)'s Caesarstone position peaked at $11.2M in Q1 2016.
  • 89 funds tracked by Wall St. Rank held Caesarstone as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.